European specialty pharma focused on CNS disorders, manufacturing and commercializing across 75+ countries
Neuraxpharm is a Spanish specialty pharmaceutical manufacturer with direct operations in 25+ countries and partnerships reaching 50+ more, focused on CNS indications spanning psychiatry, neurology, and geriatrics. The company's tech stack—SAP (ECC, S/4HANA, FICO, COPA), Veeva, IQVIA, Databricks, and MLflow—reflects a manufacturing-first organization managing complex supply chains and regulatory workflows; the adoption of Tableau signals a shift toward business intelligence on top of legacy ERP systems. Hiring is heavily weighted toward sales (24 of 64 active roles) and manufacturing (9), with notable leadership gaps in medical and regulatory affairs, indicating post-acquisition integration and portfolio expansion are operational priorities.
Notable leadership hires: Medical Lead, Head of Regulatory Affairs
Neuraxpharm develops and commercializes branded and generic CNS pharmaceuticals, with in-house manufacturing at Neuraxpharm Pharmaceuticals in Spain. The company operates a 1,000-person organization across Europe, Latin America, the Middle East, and Australia, balanced between direct commercial teams and manufacturing operations. Current activity centers on validating analytical methods, launching new products nationally, and managing the complex post-acquisition integration typical of specialty pharma—deviation tracking, batch certification, compliance documentation, and cross-functional quality assurance. The business model combines direct sales in established markets with a partner network for geographic expansion.
SAP (ECC, S/4HANA, FICO, COPA), Veeva, IQVIA, Databricks, MLflow, Azure, GCP, Salesforce, LIMS, HPLC, and HPLC-MS. Now adopting Tableau for analytics.
Headquartered in Sant Joan Despí, Barcelona. Currently hiring across Spain, Germany, Italy, France, Portugal, Australia, and Greece.
Other companies in the same industry, closest in size